80 Biggest Movers From Yesterday

Gainers

• RTI Surgical Holdings, Inc. RTIX shares surged 63.4% to close at $4.51 on Tuesday after the company announced it will sell its OEM Business for $490 million. The company also issued preliminary Q4 and FY19 sales guidance above analyst estimates.
• Inpixon INPX shares gained 54.8% to close at $5.65 after falling 9.9% on Monday.
• IRIDEX Corporation IRIX rose 48.7% to close at $3.51 after the company reported strong preliminary sales for the fourth quarter and full year 2019.
• The Peck Company Holdings, Inc. PECK gained 34.2% to close at $4.51.
• Big 5 Sporting Goods Corporation BGFV gained 31% to close at $4.06 after the company issued preliminary FY19 EPS and sales guidance.
• XBiotech Inc XBIT climbed 30.7% to close at $24.33 after the company announced it has commenced a tender offer to purchase up to $420 million of its common shares.
• Denali Therapeutics Inc. DNLI climbed 29.4% to close at $22.74 after the company reported broad pipeline progress including positive results from its LRRK2 program for Parkinson's disease.
• Ichor Holdings, Ltd. ICHR rose 28.8% to close at $39.79 after reporting strong preliminary sales for the fourth quarter.
• Super League Gaming IncSLGG gained 28.1% to close at $3.60 after the company announced a partnership with Wanda Cinemas Games.
• La Jolla Pharmaceutical Company LJPC rose 26.1% to close at $8.83 after climbing 16.67% on Monday.
• Momenta Pharmaceuticals, Inc. MNTA rose 23.7% to close at $25.36.
• Tilray, Inc. TLRY climbed 22.2% to close at $21.22. Tilray appointed Jon Levin as COO and Michael Kruteck as CFO.
• Aurora Mobile Limited JG surged 20.8% to close at $2.85.
• Rigel Pharmaceuticals, Inc. RIGL gained 20.5% to close at $2.6150.
• ACM Research, Inc. ACMR gained 20.2% to close at $31.59 after reporting preliminary 2019 revenue.
• Anixa Biosciences, Inc. ANIX shares surged 19.9% to close at $3.32.
• Sequans Communications S.A. SQNS shares rose 17.7% to close at $4.00.
• Gritstone Oncology, Inc. GRTS gained 17.6% to close at $10.45.
• Computer Task Group, Incorporated CTG gained 16.4% to close at $6.11 after the company confirmed the receipt of new unsolicited proposal from Assurance Global Services for $7 per share in cash.
• YRC Worldwide Inc. YRCW rose 16.3% to close at $2.78.
• Build-A-Bear Workshop, Inc. BBW surged 15.6% to close at $3.93. Build-A-Bear Workshop expects preliminary FY19 sales of $334 million-$338 million.
• Endo International plc ENDP gained 15.4% to close at $5.47.
• Mersana Therapeutics, Inc. MRSN rose 15.2% to close at $6.07.
• SmileDirectClub Inc SDC jumped 14.7% to close at $11.70 after the company announced its clear aligners will now be available at dentist and orthodontist offices.
• Ultra Clean Holdings, Inc. UCTT rose 14.5% to close at $25.42.
• Karuna Therapeutics, Inc. KRTX shares climbed 14.5% to close at $84.87.
• Coherus BioSciences, Inc. CHRS rose 14.4% to close at $19.89.
• Five Star Senior Living Inc. FVE gained 14.3% to close at $5.99.
• Clearside Biomedical, Inc. CLSD rose 14.3% to close at $2.40.
• ThermoGenesis Holdings, Inc. THMO gained 13.7% to close at $4.40.
• Viela Bio, Inc. VIE surged 13.2% to close at $37.55.
• Aimmune Therapeutics, Inc. AIMT rose 12.9% to close at $35.00.
• Perrigo Company plc PRGO jumped 12.6% to close at $56.91 after the company also announced strong preliminary Q4 net sales.
• Fluidigm Corporation FLDM gained 12.4% to close at $3.98 after the company issued strong preliminary Q4 and FY19 sales results.
• Fate Therapeutics, Inc. FATE rose 11.9% to close at $24.28.
• Amneal Pharmaceuticals, Inc. AMRX climbed 11.6% to close at $5.02.
• TKK Symphony Acquisition Corporation TKKS rose 11.3% to close at $10.22.
• Camtek Ltd. CAMT gained 11.2% to close at $12.68.
• Magnachip Semiconductor Corp MX rose 11.1% to close at $13.97 after the company raised preliminary Q4 sales guidance above analyst estimates.
• Five Point Holdings, LLC FPH gained 10.9% to close at $7.31 after the company announced the sale of first homesites at New Community in Los Angeles County for proceeds of $135 million.
• Applied Genetic Technologies Corporation AGTC rose 10.8% to close at $8.34.
• Merit Medical Systems, Inc. MMSI gained 10.8% to close at $38.40.
• MRI Interventions, Inc. MRIC rose 10.6% to close at $6.14.
• Zai Lab Limited ZLAB jumped 10.6% to close at $48.14.
• Accuray Incorporated ARAY rose 10.6% to close at $3.03.
• CollPlant Biotechnologies Ltd. CLGN gained 10.5% to close at $10.50.
• Amicus Therapeutics, Inc. FOLD climbed 10.5% to close at $9.86.
• Deswell Industries, Inc. DSWL rose 10.5% to close at $2.96.
• PowerFleet, Inc. PWFL gained 10.4% to close at $7.84.
• Overstock.com, Inc. OSTK surged 10.1% to close at $8.81.
• Applied Therapeutics, Inc. APLT gained 10.1% to close at $46.36.
• Vir Biotechnology, Inc. VIR gained 10.1% to close at $14.55.
• Surgery Partners, Inc. SGRY rose 9.7% to close at $16.58.
• Nautilus, Inc. NLS gained 9.7% to close at $3.72.
• Pinterest, Inc. PINS surged 9.6% to close at $21.51 following a report the company surpassed Snapchat as the third-biggest social media platform in the US in 2019, and it will continue to stay ahead in the coming years.
• Teva Pharmaceutical Industries Limited TEVA rose 9.5% to close at $10.04.
• Contura Energy, Inc. CTRA gained 8.5% to close at $8.29.
• Limoneira Company LMNR rose 5.3% to close at $20.43. Limoneira reported in-line earnings for its fourth quarter, while sales exceeded views.
• Perion Network Ltd. PERI rose 5.1% to close at $8.72 after the company reported the acquisition of Content IQ for $73.05 million.

Check out these big penny stock gainers and losers

Losers

• Eloxx Pharmaceuticals, Inc. ELOX shares tumbled 30.3% to close at $5.28 on Tuesday after the company issued update on progress of Phase 2 programs for ELX-02 and ERSG pipeline.
• Stemline Therapeutics, Inc. STML shares dipped 30.3% to close at $6.57 on Tuesday. Stemline Therapeutics announced preliminary results for 2019 and said it expects Elzonris net revenue of $43.2 million for the full year and $11.8 million for the fourth quarter. Analysts, on average, are forecasting revenueof $15.06 million for the fourth quarter and $46.44 million for the full year..
• NantKwest, Inc. NK fell 27.9% to close at $4.90. NantKwest and ImmunityBio announced complete response in metastatic pancreatic cancer in first patient to receive PD-L1 tumor-targeted natural killer cells (PD-L1.t-haNK) combined with N-803 IL-15 fusion protein.
• OneConnect Financial Technology Co., Ltd. OCFT shares declined 20.4% to close at $12.48.
• Oncolytics Biotech Inc. ONCY dropped 18.2% to close at $2.87.
• Criteo S.A. CRTO dipped 15.9% to close at $15.29.
• Motus GI Holdings, Inc. MOTS dropped 15.9% to close at $2.33.
• KBS Fashion Group Limited KBSF dipped 14.6% to close at $2.18.
• GameStop Corp. GME fell 13.3% to close at $4.71 after the company reported a 24.7% year-over-year drop in its comparable sales for the nine-week holiday period. Its holiday sales fell 27.5% year-over-year to $1.83 billion. The company said it expects preliminary FY19 comparable sales down 19%-21%.
• Fulcrum Therapeutics, Inc. FULC dropped 12.8% to close at $18.54.
• Verona Pharma plc VRNA dropped 12.7% to close at $6.31.
• PolarityTE, Inc. PTE fell 10.5% to close at $3.06.
• ADDvantage Technologies Group, Inc. AEY dipped 9.9% to close at $2.00.
• CounterPath Corporation CPAH fell 9.2% to close at $3.06 after dropping 14.03% on Monday.
• Avinger Inc AVGR fell 9.2% to close at $1.08 after the company reported a common stock offering.
• BioNTech SE BNTX fell 8.7% to close at $34.53.
• BioCardia, Inc. BCDA dipped 8.5% to close at $5.30. Biocardia announced FDA clearance for Morph DNA deflectable guide catheter.
• Aphria Inc. APHA fell 8.4% to close at $4.99 after reporting Q2 results.
• Protalix BioTherapeutics, Inc. PLX dropped 7.9% to close at $3.63.
• InMode Ltd. INMD shares fell 7.3% to close at $41.49. InMode is expected to release its Q4 results on Tuesday, February 18, 2020.
• ATIF Holdings Limited ATIF tumbled 7.2% to close at $1.8750.
• ACI Worldwide, Inc. ACIW fell 5.1% to close at $37.08 after the company lowered FY19 sales guidance below analyst estimates.